Voy is a legitimate, CQC-registered online weight management service offering prescription GLP-1 medications including semaglutide. It operates under proper UK medical regulation, which sets it apart from many unregulated competitors in this space. Consumers should be aware the service is subscription-based, cancellation complaints exist, and GLP-1 medication supply can be inconsistent.
Voy is a UK online weight management clinic operated by Manual Ltd, a men's and women's health platform founded in 2021 and registered at Companies House (13662866). The service launched around 2022 and focuses on GLP-1 receptor agonist medications such as semaglutide, prescribed remotely following an online consultation. As a CQC-registered provider with GMC-registered prescribers, it meets the baseline legal requirements for operating as a medical service in the UK.
The key strength here is regulatory legitimacy — unlike many grey-market weight loss sites selling unlicensed products, Voy operates within the UK's formal healthcare framework. However, consumer reviews on Trustpilot and Reddit flag recurring issues around subscription management, including auto-renewal charges and difficulties cancelling. There have also been reported disruptions to medication supply, which is a broader issue affecting the GLP-1 market rather than unique to Voy, but consumers should factor this risk into their decision.
UK consumers considering Voy should read the subscription terms carefully before signing up, paying particular attention to the cancellation policy and notice periods. Confirm medication availability for your specific treatment before committing to a plan. If you experience billing issues, you have protections under the Consumer Rights Act 2015 and can escalate to your card provider via chargeback if services are not delivered as described. Voy is a legitimate option in this market but is not without friction.